Histogen Correlations
HSTO Stock | USD 0.02 0.01 25.65% |
The current 90-days correlation between Histogen and Eliem Therapeutics is -0.01 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Histogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Histogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Histogen Correlation With Market
Good diversification
The correlation between Histogen and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and DJI in the same portfolio, assuming nothing else is changed.
Histogen |
Moving against Histogen Stock
0.73 | RNXT | RenovoRx | PairCorr |
0.55 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.43 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.39 | BAC | Bank of America Aggressive Push | PairCorr |
0.39 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
0.31 | PG | Procter Gamble | PairCorr |
Related Correlations Analysis
0.86 | -0.55 | 0.8 | -0.68 | ELYM | ||
0.86 | -0.54 | 0.7 | -0.58 | SCPH | ||
-0.55 | -0.54 | -0.39 | 0.51 | MIST | ||
0.8 | 0.7 | -0.39 | -0.63 | MCRB | ||
-0.68 | -0.58 | 0.51 | -0.63 | LUMO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Histogen Stock performing well and Histogen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Histogen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 3.92 | (0.78) | 0.00 | 0.73 | 0.00 | 6.21 | 34.87 | |||
SCPH | 2.64 | (0.84) | 0.00 | (0.35) | 0.00 | 4.05 | 20.70 | |||
MIST | 1.90 | 0.19 | 0.12 | 0.24 | 1.61 | 7.19 | 18.66 | |||
MCRB | 4.93 | 0.19 | 0.02 | 0.60 | 5.66 | 10.84 | 28.84 | |||
LUMO | 2.44 | 0.38 | 0.06 | (0.43) | 2.72 | 5.95 | 16.25 |
Histogen Corporate Management
Stephen Hill | VP Controller | Profile | |
Steven Mento | Interim Chairman | Profile | |
Thomas Hubka | Director Sec | Profile | |
Gail Naughton | Founder Advisor | Profile |